Image

SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations

SELVA: Testing a new gel for treating small lymphatic malformations.

Recruiting
6 years and older
All
Phase 3
  • Simplified description (AI rewritten)
  • Technical description (Original)

SELVA Study: This research is testing a gel called QTORIN 3.9% Rapamycin Anhydrous Gel to treat a condition called microcystic lymphatic malformations. These are small, fluid-filled sacs under the skin. The study will last for 24 weeks, and it's being conducted at several centers. It will check how well the gel works and if it's safe to use. Participants can also choose to continue using the gel after the initial 24 weeks.

Who can join? Anyone 6 years or older with confirmed microcystic lymphatic malformations can participate. However, those with certain other health conditions or who are pregnant cannot join.

  • Study duration is 24 weeks, with an option to continue longer.
  • Participants must attend regular check-ups to monitor progress and safety.
  • Potential risks and benefits will be discussed during the consent process.
Print
Study details
    Microcystic Lymphatic Malformation

NCT06239480

Palvella Therapeutics, Inc.

5 April 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.